US Stock MarketDetailed Quotes

GRCE Grace Therapeutics

Watchlist
  • 3.820
  • -0.240-5.91%
Close Dec 20 16:00 ET
  • 3.820
  • 0.0000.00%
Post 20:01 ET
38.73MMarket Cap-4.20P/E (TTM)

Grace Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Grace Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 0.000--
--2025/Q3-- / 0.000--
--2025/Q20.000 / 0.000--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 0.000--
--2025/Q3-- / 0.000--
--2025/Q20.000 / 0.000--
--2025/Q10.000 / 0.000--
--2024/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Grace Therapeutics Earnings Reports

  • Grace Therapeutics | 8-K: Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update

    Nov 13 08:02 ET

  • Grace Therapeutics | 10-Q: Q2 2025 Earnings Report

    Nov 13 07:33 ET

  • Acasti Pharma | 8-K: Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update

    Aug 9 08:02 ET

  • Acasti Pharma | 10-Q: Q1 2025 Earnings Report

    Aug 9 07:32 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Ermenegildo Zegna NV
    ZGN
    +6.16%
    DexCom
    DXCM
    +5.57%
    New Fortress Energy
    NFE
    +5.37%
    Workday
    WDAY
    +2.33%
    eBay
    EBAY
    +1.66%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data